Hyaluronic Acid Products Sales to Witness 2X Expansion Through 2029
Escalating demand for minimally invasive treatment methods has been pushing consumption of hyaluronic acid products, particularly in the field of orthopedics. Rising prevalence of osteoarthritis and the subsequent increase in number of hyaluronic acid product prescriptions for knee and hip joints warrant a progressive growth outlook for the global hyaluronic acid products market. This study projects that the market revenues will almost double over 2019 – 2029. Skincare is set to emerge as a highly profitable application area of hyaluronic acid products.
Key Growth Influencers - Hyaluronic Acid Products Market
Hyaluronic Acid Products Easing Osteoarthritis Patients
There has been a rise in the number of osteoarthritis patients seeking alternate options for knee replacement in view of avoiding side effects associated with NSAID and corticosteroid injections. In the market, this factor has changed the overall scenario in the pharmaceuticals industry, propelling the inclination of players in the market towards hyaluronic acid products. Most of the hyaluronic acid products available in the market are prescribed for hip joints along with knee, for example, Synvisc is approved for its application in knee as well as hip joints. Also, ‘orthovisc-mini’ of Anika is approved for all joints in Europe, contributing a fair share in hyaluronic acid products market.
Physicians across the world are still skeptical about prescribing this product for other joints apart from knee, due to less available data on the clinical safety and efficacy of these hyaluronic acid products for other joints. This factor is propelling manufacturers to increase research and development of these products for use in other joints as well.
Introduction of Next-Generation Products
IAHA (intra-articular hyaluronic acid) injection manufacturers are constantly improving their research and development in pursuit of enhancing their well-established presence in the IAHA injection market with new combination of hyaluronic acid products. Such competitive atmosphere is expected to benefit the growth of the hyaluronic acid products market. Due to excellent physiochemical properties of hyaluronic acid products, these can be easily combined with other pharmaceuticals such as corticosteroids. This factor is expected to boost the growth of the hyaluronic acid products market.
For instance, Anika’s product - Cingal, which is indicated as a viscoelastic supplement or a substitute for synovial fluid in human joints as well as a viscosupplementation product of third generation. Thus, the growth of the hyaluronic acid products market, during the forecast period, is expected to be driven by increasing R&D investments to find new avenues to combine hyaluronic acid products with other drugs.
Hyaluronic Acid Products Market Structure Analysis
- The worldwide hyaluronic acid products market is a fairly competitive market. Allergan plc, Anika Therapeutics Inc., Sanofi, Smith & Nephew and Zimmer Biomet are the major key players contributing to the maximum market share in terms of revenue.
- Business expansion through acquisitions, mergers, partnerships and collaborations are policies pursued by major participants in the hyaluronic acid products market.
- Notable R&D investments and growing demand for clinical and aesthetic use of hyaluronic acid products are expected to elevate the growth opportunities for the hyaluronic acid products market.
- Leading companies participating in the hyaluronic acid products market are Allergan plc, Anika Therapeutics Inc., Sanofi, Zimmer Biomet and Smith & Nephew.
- The local and global business participants are benefiting from a significant marketing network of distributors in regional and foreign lands.
Three Cycle Injection Products Remain Highly Preferred
Owing to high convenience attributes, usage of three cycle injection products in addressing knee osteoarthritis (OA) remains prominent, especially in the developed regional markets. Manufacturers of three cycle injection products will reap profits worth of over US$2 Bn by 2029 end. Single cycle injection products also account for a significant market share and their application in non-invasive treatments will increase at a promising rate in the following years.
US Market to Hit US$ 1 Bn Mark by 2025
North America remains leading market for hyaluronic acid product sales, with more than a third of market revenues. Worthwhile growth opportunities existing in the U.S. market would push the growth country’s hyaluronic acid products market growth will surpass the US$ 1 Bn mark by 2025. Favorable reimbursement policies and regulatory approvals for intra-articular hyaluronic acid (IAHA) injections are responsible for the market growth in the region. Increasing adoption of dermal fillers such as Macrolane and Puragen for cosmetic applications is boosting the hyaluronic acid products market in Western Europe. The U.K. and Germany, collectively accounting for about 40% share, drive the regional market. The market in Asia Pacific excluding Japan (APEJ) also reflects lucrative growth potential primarily attributing to the flourishing medical tourism in countries – Thailand, Singapore, Malaysia, and India.
* This data is only a representation. Actual data may vary and will be available in report.
Stakeholders Tapping White Spaces in Dermatology
Hyaluronic acid is finding significant application as a hydrating agent in various skincare formulations. Manufacturers of hyaluronic acid products must be proactive in responding to the ever-growing demand for clean, green, and vegan cosmetic products. Development of products such as dermal fillers for their dermatological application continues to trend in global market. For an instance, Puragen is a non-animal based hyaluronic acid gel marketed for its role in smoothening lines, banishing wrinkles, plumping lips, and filling depressions and scars. Furthermore, Macrolane is a semi-permanent dermal filler available for non-surgical breast enlargement.
High preference for three cycle injection products
Single cycle injection products to gain traction
Surging application in osteoarthritis
Increasing usage in dermal fillers
Maximum sales via hospital pharmacies
Sales through specialty clinics to gather momentum
How Growth will Unfold
Hospital pharmacies are the current the key revenue generators for hyaluronic acid product developers. However, there are strong indications of market players shifting towards specialty clinics for product distribution towards the end of the forecast period. Revenue generation of hyaluronic acid products market through both the sales channels will cross US$ 1.5 Bn over the next decade. Furthermore, sales of hyaluronic acid products via retail pharmacies and drug stores collectively account for over 40% of the total market share.
* This data is only a representation. Actual data may vary and will be available in report.Click Here To Know How The Growth Will Unfold
Custom Market Research Services
FMI offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.
Hyaluronic Acid Products Market Analysis 2019-2029
A recent market study published by Future Market Insights on the hyaluronic acid products market includes global industry analysis for 2014-2018 & opportunity assessment for 2019-2029, and delivers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical as well as current growth parameters of the hyaluronic acid products market, the growth prospects of the market are obtained with maximum precision.
Hyaluronic Acid Products Market Taxonomy
The global hyaluronic acid products market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.
- Single Cycle Injection
- Three Cycle Injection
- Five Cycle Injection
- Dermal Fillers
- Vesicoureteral Reflux
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- Specialty Clinics
- North America
- Latin America
- Western Europe
- Eastern Europe
- Middle East and Africa
The report initiates with the executive summary of the hyaluronic acid products market, which includes a summary of key findings and statistics of the market. It also includes drivers and trends pertaining to the hyaluronic acid products market.
Readers can find the definition and a detailed segmentation of the hyaluronic acid products market in this chapter, which will help them understand the basic information about the hyaluronic acid products market. Along with this, comprehensive information pertaining to hyaluronic acid products and their properties are provided in this section. This section also highlights the inclusions and exclusions, which helps the reader understand the scope of the hyaluronic acid products market report.
This section gives information about drivers, and restraints of the hyaluronic acid products market. This section also includes various opportunities and key trends of the hyaluronic acid products market.
This section gives information about upcoming pipeline products, PEST analysis, Porter’s Five Forces Model, and regulatory scenario of the hyaluronic acid products market.
This section explains the global market value analysis and forecast for the hyaluronic acid products market between the forecast periods of 2019-2029. This chapter includes a detailed analysis of the historical hyaluronic acid products market, along with an opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2019), and an incremental $ opportunity for the forecast period (2019–2029).
Based on product, the hyaluronic acid products market is segmented into single cycle injection products, three cycle injection products and five cycle injection products. In this chapter, readers can find information about the key trends and developments in the hyaluronic acid products market and market attractiveness analysis based on product.
Based on application, the hyaluronic acid products market is segmented into osteoarthritis, ophthalmic, dermal fillers and vesicoureteral reflux. In this chapter, readers can understand the market attractive analysis based on application.
This chapter provides details about the hyaluronic acid products market based on the distribution channel, and has been classified into hospital pharmacies, retail pharmacies, drug stores and specialty clinics. In this chapter, readers can understand the market attractive analysis based on distribution channel.
This chapter explains how the hyaluronic acid products market will grow across various geographic regions such as North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan (APEJ), Japan, and Middle East & Africa (MEA).
This chapter includes a detailed analysis of the growth of the North America hyaluronic acid products market, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find the regional trends, and market growth based on the product, application, distribution channel, and countries in North America.
This chapter provides the growth scenario of the hyaluronic acid products market in Latin American countries such as Brazil, Mexico, and the Rest of Latin America. Along with this, assessment of the market across target segments has been provided.
Important growth prospects of the hyaluronic acid products market based on its end users in several countries such as the U.K., France, Germany, Spain, Italy, Nordic Countries and the Rest of Western Europe are included in this chapter.
Important growth prospects of the hyaluronic acid products market based on its end users in several countries such as Russia, Poland and the Rest of Eastern Europe are included in this chapter.
In this chapter, China, India, Australia and New Zealand, ASEAN and Rest of Asia Pacific countries are the prominent countries in the Asia Pacific excluding Japan region that are the prime subjects of assessment to obtain the growth prospects of the APEJ hyaluronic acid products market. Readers can find detailed information about the growth parameters of the APEJ hyaluronic acid products market during the forecast period of 2019-2029.
This section highlights the growth prospects of the hyaluronic acid products market for Japan, during the forecast period of 2019-2029.
This chapter provides information about how the hyaluronic acid products market will grow in major countries in the MEA region such as GCC Countries, South Africa, and the Rest of MEA, during the forecast period of 2019-2029.
In this chapter, readers can find a comprehensive list of all the prominent stakeholders in the hyaluronic acid products market, along with a detailed information about each company, which includes company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are Allergan plc, Anika Therapeutics Inc., Shanghai Jingfeng Pharmaceutical Co., Ltd., Ferring Pharmaceuticals, Nestle Skin Health Company (Galderma), Sanofi, Bausch Health Companies Inc. (Salix Pharmaceuticals, Inc.), Smith & Nephew, Zimmer Biomet, Seikagaku Corporation and Fidia Farmaceutici s.p.a.
This chapter includes a list of acronyms and assumptions that provides a base to the information and statistics included in the hyaluronic acid products market report.
This chapter help readers understand the research methodology followed to obtain various conclusions as well as important qualitative and quantitative information about the hyaluronic acid products market.
How the research was conducted?
- C - Level Executives
- Marketing Directors
- Product Managers
- Business Development Officers
- Production Managers
- Procurement Heads
- Sales Executives
- Raw Material Suppliers
- Industry Experts
- End Users
- Current Market Dynamics and Challenges
- Yesteryear Trends
- Market Characteristics
- Market Performance and Growth Quadrants
- Competition Structure and Market Structure
- Strategic Growth Initiatives
- Near-term and Long-term Market Growth Prospects
- Market Segment Splits and Authenticity
- Opinions on Market Projections and Validity of Assumptions
- Industry Publications
- International journal of biological macromolecules
- Journal of drugs in dermatology
- Journal of Clinical and Aesthetic Dermatology
- Industry Associations
- American Academy of Orthopedics Surgeons Administration
- Osteoarthritis Research Society International
- Department of Health and Human Services
- European League Against Rheumatism
- Company Press Releases
- Annual Reports and Investor Presentations
- Research Papers
- Government Websites and Publications
- Trade Websites
Primary Interview Splits
Hyaluronic Acid Products Market Reports - Table of Contents
18. Assumptions and Acronyms Used
19. Research Methodology